Background
Studies performed in mice have shown that a substantial proportion of memory CD8 T cells persisting after the clearance of antigen (Ag) have the ability to secrete IL-2 in addition to IFN-γ (1,2). The wide heterogeneity of CD8 T cell responses has been proposed to be dependent upon the type of the pathogen in human virus infections (3) . In the present study we have studied memory CD8 T cells responses in different virus infections characterized by complete clearance (Flu) of Ag, repetitive Ag exposure (EBV and CMV chronic infections) and Ag persistence (HIV-1).
HIV-1 specific CD8 T cells responses were investigated in subjects with progressive and non-progressive infection while the other virus specific responses were investigated in HIV-1 negative subjects.
Methods
Functional characterization (secretion of IFN-γ and IL-2 as well as proliferation capacity) of HIV-1-, CMV-, EBV-and Flu-specific CD8 T cells were performed in peripheral blood of 21 HIV-1 infected progressors with no previous ART, 5 HIV-1 longterm non-progressors (LTNP) and in 28
HIV-1 negative subjects. Cells were stained with mAbs to CD8, CD69, IFN-γ and IL-2, CD45RA and CCR7. For examination of cell proliferation cells were labeled with CFSE and analyzed by multi-parametric flow cytometry. For depletion experiment cells were stained with CD4-APC and sorted for APC-negative cells. Statistical significance was calculated by 2 tails student t test.
Results

Distinct cytokine secreting populations of virus-specific CD8 T cells.
Representative examples obtained from the analysis of 21 HIV-1-infected progressors and 28 HIV-1-negative blood donors in whom CMV-, EBV-or Flu-specific CD8 T cell responses were detected are shown in Figure 1A . Dual IFN-γ/IL-2 secreting cells were absent in HIV-1-specific CD8 T cells whereas they were found within the other virus-specific CD8 T cells. These observations were confirmed by the analysis of a larger number of subjects. A significant difference was found between the percentage of HIV-1-specific IFN-γ/IL-2-secreting CD8 T cells (P<0.05) of the other virus infections (Fig. 1B) .We also evaluated the proportion of IL-2 secreting cells within IFN-γ secreting CD8 T cells. Cumulative data are shown in Figure 1C . Flu-specific CD8 T cells showed the highest proportion of IL-2 secretion. 
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We then determined the proliferation of HIV-1-specific CD8 T cells after stimulation with HIV-1-derived peptide pools in progressors and LTNP. HIV-1-specific CD8 T cell proliferation was barely detected or absent in these two representative progressors (2 out of 9 each tested with 1-3 peptide pools) (Fig. 4B) . However CD8 T cells of progressors were able to proliferate following stimulation with SEB indicating a selective loss of HIV-1-specific proliferation. Consistently with what has previously been shown by Migueles et al. (5) , vigorous HIV-1-specific CD8 T cell proliferation was observed in 2 representative (out of 5) LTNP (Fig. 4C) .
We then determined the correlation between the proportion of Ag-specific proliferating CD8 T cells and the proportion of IL-2 secreting CD8 T cells within IFN-γ secreting cells. This analysis was performed by pooling together 32 individual determinations of Ag-specific CD8 T cell proliferation and IL-2 secreting CD8 T cells. We found a significant correlation (P<0.02) between the proportion of Ag-specific IL-2 secreting and proliferating CD8 T cells (Fig. 4D) .
Proliferation capacity of virus-specific CD8 T cells.
In the present study we investigated a) the correlation between the ability of virus-specific CD8 T cells to secrete IL-2 and their proliferation capacity and b) the potential mechanism responsible for Ag-specific CD8 T cell proliferation. Representative examples of the proliferation capacity of CMV-, EBV-, Flu-and HIV-1-specific CD8 T cells after virus-specific stimulation are shown in Figure 4A -C. Cells were stimulated for 5 days with virus-derived peptides and proliferation was measured by the loss of CFSE in the dividing cells. A substantial proportion of CD8 T cells proliferated after stimulation with CMV-, Flu-, or EBV-derived peptides (Fig. 4A) .
We then investigated the mechanism responsible for Ag-specific CD8 T cell proliferation. Firstly, we assessed Ag-specific CD8 T cell proliferation under experimental conditions excluding the involvement of CD4 T cells. For this purpose, Ag-specific CD8 T cell proliferation was determined using either MHC class I tetramers as stimuli or CD4 T cell depleted populations in absence of exogeneous IL-2. HLA-A2 tetramer complexed with Flu-or CMV-derived peptides induced vigorous Ag-specific proliferation of CD8 T cells of subjects 172 and 180 (Fig. 5A) . No CD4 T cell proliferation was observed (Fig. 5A ) thus indicating that Ag-specific CD8 T cell proliferation was not associated with the stimulation of Ag-specific helper CD4 T cells.
HIV-1-specific CD8 T cell proliferation was barely detected in progressors after stimulation with HLA-A2 tetramer complexed with an HIV-1 pol derived peptide (Fig. 5B) . The proliferation capacity was recovered in presence of exogeneous IL-2 (Fig. 5B) . No proliferation was observed in CD4 T cells after stimulation with tetramers (Fig. 5B) . A.
In order to further confirm the hypothesis of CD4-independent CD8 T cell proliferation we compared HIV-1-specific CD8 T cell proliferation in response to a p24-derived peptide in CD4-depleted and unfractionated T cell populations, respectively. Patient 1010 had constantly controlled viremia since four years after interruption of antiviral therapy. A large percentage (59%) of HIV-1-specific CD8 T cell proliferated after stimulation of unfractionated cell populations with p24-derived peptide (Fig. 6A) . Substantial HIV-1-specific CD8 T cell proliferation (32.7%) occurred also in CD4 T celldepleted populations although it was reduced compared to the cultures containing CD4 T cells. This proliferation was not due to contaminating CD4 T cells since they were almost absent (0.6%) in the depleted population.
Last CD8 T cell proliferation was assessed in presence of anti-IL-2 antibodies. The substantial CD8 T cell proliferation of subject 180 observed after stimulation with a CMV-tetramer was completely abolished (95% inhibition of proliferation) in presence of the anti-IL-2 antibodies (Fig. 6B) . 
